The potential role of aryl hydrocarbon receptor in Alzheimer's disease: Protective or detrimental
Ageing Research Reviews · 2025-08 · 110 · 102810
DOI: 10.1016/j.arr.2025.102810 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Ageing Research Reviews, 2025-08. Verfasst von Hayder M Al-Kuraishy und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Clinical pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq. Hauptthemen laut MEDLINE: Alzheimer Disease, Receptors, Aryl Hydrocarbon, Brain. Die Arbeit wurde bisher 20-mal zitiert (Crossref) und nennt 93 Literaturangaben. Gefördert von: University of Bisha.
Themen: Demenz
Abstract (Originalsprache)
Alzheimer's disease (AD) is the main cause of dementia in the old-age population worldwide. AD is a progressive brain neurodegenerative disease due to genetic and environmental factors that induce the accumulation of intracellular hyperphosphorylated tau protein and extracellular amyloid protein (Aβ). Particularly, cholinergic neurons in the prefrontal cortex and hippocampus are mainly affected in AD, resulting in cognitive impairment and memory dysfunction. Therefore, restoration of cholinergic neurotransmission by cholinergic agonists such as tacrine and donepezil could be effective in the management of AD. However, anti-AD medications cannot reverse the fundamental AD neuropathology. Therefore, targeting other pathways might be reasonable in the management of AD. Interestingly, aryl hydrocarbon receptors (AHRs), which are sensors for xenobiotics and enterobiotics, are involved in age-related neurodegeneration. It has been shown that AHRs have detrimental effects on AD neuropathology by disruption of BBB integrity and induction of cognitive impairment. Conversely, activation of brain AHRs by tryptophan attenuates the inflammatory reactions in AD. These findings emphasized the controversial roles of AHRs in the pathogenesis of AD. Therefore, this review discusses the exact role of AHRs in AD regarding the molecular mechanisms and related signaling pathways.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Clinical pharmacology and Medicine, College of Medicine, Mustansiriyah University, Baghdad, Iraq.
- Department of Gynecology and Obstetrics, College of Medicine, Mustansiriyah University, Baghdad 14132, Iraq.
- Department of Biotechnology, College of Applied Sciences, University of Technology, Baghdad, Iraq. Electronic address: ghassan.m.sulaiman@uotechnology.edu.iq.
- Department of Medicinal Chemistry and Pharmacognosy, College of Pharmacy, Qassim University, Qassim 51452, Saudi Arabia.
- Jabir ibn Hayyan Medical University, Najaf, PO.Box 13, Al-Ameer Qu, Kufa, Iraq.
- Department of Medical Laboratory Sciences, College of Applied Medical Sciences, University of Bisha, 255, Bisha 67714, Saudi Arabia.
Förderung
- University of Bisha
Zitieren
APA
Al-Kuraishy, H. M., Al-Maiahy, T. J., Sulaiman, G. M., Mohammed, H. A., Albuhadily, A. K., Al-Gareeb, A. I., & Abomughaid, M. M. (2025). The potential role of aryl hydrocarbon receptor in Alzheimer's disease: Protective or detrimental. Ageing Research Reviews, 110, 102810. https://doi.org/10.1016/j.arr.2025.102810
Vancouver
Al-Kuraishy HM, Al-Maiahy TJ, Sulaiman GM, Mohammed HA, Albuhadily AK, Al-Gareeb AI, et al. The potential role of aryl hydrocarbon receptor in Alzheimer's disease: Protective or detrimental. Ageing Research Reviews. 2025;110:102810. doi:10.1016/j.arr.2025.102810
BibTeX
@article{AlKuraishy2025,
author = {Al-Kuraishy, Hayder M and Al-Maiahy, Thabat J and Sulaiman, Ghassan M and Mohammed, Hamdoon A and Albuhadily, Ali K and Al-Gareeb, Ali I and Abomughaid, Mosleh M},
title = {The potential role of aryl hydrocarbon receptor in Alzheimer's disease: Protective or detrimental},
journal = {Ageing Research Reviews},
year = {2025},
volume = {110},
pages = {102810},
doi = {10.1016/j.arr.2025.102810}
}
EUVIMED